Advertisement

Molecular and Cellular Biochemistry

, Volume 168, Issue 1–2, pp 133–139 | Cite as

b-adrenergic modulation of FMLP- and zymosan-induced intracellular and extracellular oxidant production by polymorphonuclear leukocytes

  • S. Kopprasch
  • A. Gatzweiler
  • J. Graessler
  • H.-E. Schröder
Article

Abstract

Evaluation of catecholamine modulation of PMNL extracellular and intracellular oxidant production may reflect beneficial and harmful effects of b-adrenergic agonists in various disease states. We investigated the kinetics and potency of adrenaline-mediated inhibition of oxidant generation in FMLP- and zymosan-stimulated PMNLs. In FMLP-stimulated cells, the short-term burst of oxidant generation was inhibited by adrenaline in a dose-dependent fashion. Intra- and extracellular chemiluminescence and extracellular superoxide anion and hydrogen peroxide generation showed similar IC50 values for adrenaline (1.3-3.0 ï 10-8 M) indicating that both extracellular and intracellular events were inhibited with the same potency. In contrast, intracellular oxidant production evoked by the phagocytosis of zymosan was only minimally affected by 3 ï 10-5 - 3 ï 10-12 M adrenaline. Extracellular inhibition of oxidant production was also apparent in zymosan-stimulated cells. In conclusion, adrenaline's ability to depress extracellular generation of oxygen metabolites while retaining prolonged intracellular oxidant production for phagocytosis supports its beneficial role as selectively targeted physiological protector.

catecholamines chemiluminescence leukocytes hormones inflammation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Henson PM, Henson JE, Fittschen C, Bratton DL, DWH Riches: Degranulation and secretion by phagocytic cells. In: JI Gallin, IM Goldstein and R Snyderman (eds). Inflammation: Basic Principles and Clinical Correlates. Raven Press, New York, 1992, pp 511–539Google Scholar
  2. 2.
    Smith JA: Neutrophils, host defense, and inflammation: a double-edged sword. J Leukocyte Biol 56: 672–686, 1994Google Scholar
  3. 3.
    Lanser ME, Mao P, Brown G, Coleman B, JH Siegel: Serum mediated depression of neutrophil chemiluminescence following blunt trauma. Ann Surgery 202: 111–118, 1985Google Scholar
  4. 4.
    Polk HC, George CD, Hershman MJ, Welihausen SR, Chedale WG: The capacity of serum to support neutrophil phagocytosis is a vital host defense mechanism in severely injured patients. Ann Surgery 207: 686–692, 1988Google Scholar
  5. 5.
    Bjornson AB, Somers SD, Knippenberg RW, HS Bjornson: Circulat-ing factors contribute to elevation of intracellular cyclic-3′,5′-adenos-ine monophosphate and depression of superoxide anion production in polymorphonuclear leukocytes following thermal injury. J Leukocyte Biol 52: 407–414, 1992Google Scholar
  6. 6.
    Alexander JW, Stinnett JD, Ogle CK, Ogle JD, MJ Morris: A com-parison of immunologic profiles and their influence on bacteremia in surgical patients with a high risk of infection. Surgery 86: 94–104, 1979Google Scholar
  7. 7.
    Repine JE, CJ Beehler: Neutrophils and adult respiratory stress syndrome: two interlocking perspectives in 1991. Am Rev Respir Dis 144: 251–259, 1991Google Scholar
  8. 8.
    Labro MT, Benna JE, Charlier N, Abdelghaffar H, J Hakim: Cefdinir (Cl-983), a new oral amino-2-thiazolyl cephalosporin, inhibits human neutrophil myeloperoxidase in the extracellular medium but not in the phagolysosome. J Immunol 152: 2447–2455, 1994Google Scholar
  9. 9.
    Mueller H, Montoya B, LA Sklar: Reversal of inhibitory pathways in neutrophils by protein kinase antagonists: a rational approach to the restoration of depressed cell function? J Leukocyte Biol 52: 400–406, 1992Google Scholar
  10. 10.
    Tecoma ES, Motulsky HJ, Traynor AE, Omann GM, Muller H, LA Sklar: Transient catecholamine modulation of neutrophil activation: kinetic and intracellular aspects of isoproterenol action. J Leukocyte Biol 40: 629–644, 1986Google Scholar
  11. 11.
    Mack JA, Nielson CP, Stevens DL, RE Vestal: β-adrenoceptor-medi-ated modulation of calcium ionophore activated polymorphonuclear leukocytes. Br J Pharmacol 88: 417–423, 1986Google Scholar
  12. 12.
    Nielson CP: b-adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation. J Immunol 139: 2392–2397, 1987Google Scholar
  13. 13.
    Mueller H, Motulsky HJ, LA Sklar: The potency and kinetics of the b-adrenergic receptors on human neutrophils. Mol Pharmacol 34: 347–353, 1988Google Scholar
  14. 14.
    Bazzoni G, Dejana E, AD Maschio: Adrenergic modulation of human polymorphonuclear leukocyte activation. Potentiating effect of adenosine. Blood 77: 2042–2048, 1991Google Scholar
  15. 15.
    Busse WW, JM Sosman: Isoproterenol inhibition of isolated human neutrophil function. J Allergy Clin Immunol 73: 404–410, 1984Google Scholar
  16. 16.
    Quinn MT: Low-molecular-weight GTP-binding proteins and leukocyte signal transduction. J Leukocyte Biol 58: 263–276, 1995Google Scholar
  17. 17.
    Kopprasch S, Gatzweiler A, Kohl M, H.-E. Schröder: Endothelin-1 does not prime polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites. Inflammation 19: 679–687, 1995Google Scholar
  18. 18.
    Dahlgren C: Effects on extra-and intracellularly localized, chemo-attractant-induced, oxygen radical production in neutrophils following modulation of conditions for ligand-receptor interaction. Inflammation 12: 335–349, 1988Google Scholar
  19. 19.
    Hyslop PA, LA Sklar: A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes. Anal Biochem 141: 280–286, 1984Google Scholar
  20. 20.
    Kopprasch S, Graessler J, Seibt R, Naumann H-J, Wiedemann B: Laboratory stress in normotensives, borderline hypertensives and essential hypertensives is associated with priming of phagocytic cells. Stress Medicine 12: 9–16, 1996Google Scholar
  21. 21.
    Ratge D, Wiedemann A, Kohse KP, Klar H, Hellberg K, Wisser H: Magnitude and kinetics of alterations in plasma catecholamines and leukocyte beta-adrenergic receptors in response to anaesthesia and surgery. J Clin Chem Clin Biochem 28: 391–398, 1990Google Scholar
  22. 22.
    Rabinowitz B, Hod H, Elazar E, Klein R, Neufeld HN: Hemodynamics, circulating catecholamines, and response to intravenous nitrate therapy in a specific subset of acute myocardial infarction: the hypertensive-hyperkinetic-coronary-active group. Cardiology 75: 260–268, 1988Google Scholar
  23. 23.
    Tosti-Croce C, Lucarelli C, Betto P, Floridi A, Rinaldi R, Salvati A, Taggi F, Sciarra F: Plasma catecholamine responses during a personalized physical stress as a dynamic characterization of essential hypertension. Physiol Behav 49: 685–690, 1991Google Scholar
  24. 24.
    Ding Z, Jiang M, Li S, Zhang Y: Vascular barrier enhancing effect of an endogenous b-adrenergic agonist. Inflammation 19: 1–8, 1995Google Scholar
  25. 25.
    Josefsson E, Mansson JE, Blennow K, A Tarkowski: Immuno-modulating and anti-inflammatory properties of the sympatholytic compound 6-hydroxydopamine. J Neuroimmunol 55: 161–169, 1994Google Scholar
  26. 26.
    van-der-Poll T, Jansen J, Endert E, Sauerwein HP, van Deventer SJ: Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 62: 2046–2050, 1994Google Scholar
  27. 27.
    Briheim G, Follin P, Sandstedt S, Dahlgren C: Relationship between intracellularly and extracellularly generated oxygen metabolites from primed polymorphonuclear leukocytes differs from that obtained from nonprimed cells. Inflammation 13: 455–464, 1989Google Scholar
  28. 28.
    Wilhelm J, Vilim V: Variables in xanthine oxidase-initiated luminol chemiluminescence: implications for chemiluminescence measurements in biological systems. Anal Biochem 158: 201–210, 1986Google Scholar
  29. 29.
    Vilim V, Wilhelm J: What do we measure by a luminol dependent chemi-luminescence of phagocytes? Free Rad Biol Med 6: 623–629, 1989Google Scholar
  30. 30.
    Allen RC: Role of oxygen in phagocyte microbicidal action. Environ. Health Perspect 102(Suppl 110): 201–208, 1994Google Scholar
  31. 31.
    Torres M, Hall FL, O'Neill K: Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. J Immunol 150: 1563–1578, 1993Google Scholar
  32. 32.
    Bengtsson T, Dahlgren C, Stendahl O, Andersson T: Actin assembly and regulation of neutrophil function: effects of cytochalasin B and tetracaine on chemotactic peptide-induced O2 – production and degranulation. J Leukocyte Biol 49: 236–244, 1991Google Scholar
  33. 33.
    Patel PD, Zimmermann GA, Prescott SM, McEver RP, McIntyre TM: Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 112: 749–759, 1991Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • S. Kopprasch
    • 1
  • A. Gatzweiler
    • 1
  • J. Graessler
    • 1
  • H.-E. Schröder
    • 1
  1. 1.Department of Internal Medicine lIl, Pathological BiochemistryTechnical University of Dresden, Carl Gustav Carus Medical SchoolDresdenGermany

Personalised recommendations